Hematologic Malignancy

B-Cell Non-Hodgkin Lymphoma

Hematologic1,757 active trials43 approved drugs73 evidence items

NCIt: C3457
OncoTree: MBN
UMLS CUI: CL448793

Clinical trials

Registered studies

6,180 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,757
Recruiting: 905
Ph III recruiting: 103
Growth YoY: +6.8%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (953)

No study matches these filters